TN-401

N/A

Report date: 2023/10/27 13:36:35

Base Information

Drug NameTN-401
Drug Alias NameTN-401
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transferencePlakophilin-2 gene transference
TargetsPlakophilin-2
Therapy Area/IndicationsCardiomyopathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTenaya Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTenaya Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCardiomyopathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A